FR3039402B1 - Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral - Google Patents
Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebralInfo
- Publication number
- FR3039402B1 FR3039402B1 FR1557321A FR1557321A FR3039402B1 FR 3039402 B1 FR3039402 B1 FR 3039402B1 FR 1557321 A FR1557321 A FR 1557321A FR 1557321 A FR1557321 A FR 1557321A FR 3039402 B1 FR3039402 B1 FR 3039402B1
- Authority
- FR
- France
- Prior art keywords
- prevention
- treatment
- intervertebral disc
- injection solution
- disc degeneration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1557321A FR3039402B1 (fr) | 2015-07-30 | 2015-07-30 | Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1557321A FR3039402B1 (fr) | 2015-07-30 | 2015-07-30 | Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3039402A1 FR3039402A1 (fr) | 2017-02-03 |
| FR3039402B1 true FR3039402B1 (fr) | 2017-08-25 |
Family
ID=55759654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1557321A Active FR3039402B1 (fr) | 2015-07-30 | 2015-07-30 | Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR3039402B1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115105464B (zh) * | 2022-08-31 | 2022-12-02 | 山东大学齐鲁医院 | 一种纳米复合水凝胶及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002221370A1 (en) * | 2000-11-15 | 2002-05-27 | Bio Syntech Canada Inc | Method for restoring a damaged or degenerated intervertebral disc |
| FR2983070B1 (fr) * | 2011-11-30 | 2014-04-25 | Cytosial Biomedic | Solution aqueuse homogene de chitosane injectable |
-
2015
- 2015-07-30 FR FR1557321A patent/FR3039402B1/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR3039402A1 (fr) | 2017-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3399923C0 (fr) | Système pour le traitement d'une obstruction microvasculaire | |
| IL247111A0 (en) | Preventive or therapeutic agent for kidney disease | |
| SI3110418T1 (sl) | Arilne, heteroarilne in heterociklične spojine za zdravljenje s komplementom posredovanih motenj | |
| HRP20181130T1 (hr) | Postupci za liječenje infekcija virusom filoviridae | |
| MA39748A (fr) | Cenicriviroc pour le traitement de la fibrose | |
| EP3324965A4 (fr) | Modulateurs de la gamma-sécrétase pour le traitement de dysfonctionnement du système immunitaire | |
| BR112016022062A2 (pt) | Combinação, composição farmacêutica, uso de uma combinação ou de uma composição farmacêutica, e, produto farmacêutico | |
| IL255185A0 (en) | 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto | |
| ZA201700416B (en) | Methods for treating or preventing ophthalmological conditions | |
| EP3102220C0 (fr) | Compositions de complément alimentaire synergique pour la prévention, le traitement ou la régulation de troubles inflammatoires | |
| LT3157531T (lt) | Žarnyno enteroendokrininės sistemos stimuliavimo būdai ir kompozicijos, skirtos su ja susijusioms ligoms arba būklėms gydyti | |
| GB201611712D0 (en) | Methods and compounds for the treatment or prevention of severe or persistent influenza | |
| EP3341398C0 (fr) | Composés destinés à induire une formation de tissu et utilisations de ces composés | |
| IL247116A0 (en) | Compositions and methods for treating and preventing macular degeneration | |
| LT3153511T (lt) | 2-acilaminotiazolo dariniai, skirti panaudoti šlapimo pūslės/šlapimo takų ligų prevencijai arba gydymui | |
| IL252431B (en) | 15-hepe or a composition comprising 15-hepe for treating or preventing fibrosis | |
| EP3493823C0 (fr) | Composé à base de postbiotique pour le traitement de l'inflammation oculaire | |
| EP3329929A4 (fr) | Composition pharmaceutique pour la prévention ou le traitement de la sécheresse oculaire | |
| EP3352684C0 (fr) | Système pour le traitement d'une épistaxis | |
| MA40687A (fr) | Méthodes et compositions de traitement de malformation vasculaire | |
| GB201504387D0 (en) | Materials and methods for the treatment of vascular disease | |
| ES2894844T8 (es) | Tratamiento de la calcificación vascular | |
| EP3511011A4 (fr) | Composition pour prévenir ou améliorer la fatigue oculaire | |
| FR3022139B1 (fr) | Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee | |
| EP3626256C0 (fr) | Composition pour le traitement des lésions tissulaires |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 2 |
|
| PLSC | Publication of the preliminary search report |
Effective date: 20170203 |
|
| PLFP | Fee payment |
Year of fee payment: 3 |
|
| PLFP | Fee payment |
Year of fee payment: 4 |
|
| PLFP | Fee payment |
Year of fee payment: 5 |
|
| PLFP | Fee payment |
Year of fee payment: 6 |
|
| PLFP | Fee payment |
Year of fee payment: 7 |
|
| PLFP | Fee payment |
Year of fee payment: 8 |
|
| PLFP | Fee payment |
Year of fee payment: 9 |
|
| PLFP | Fee payment |
Year of fee payment: 10 |
|
| PLFP | Fee payment |
Year of fee payment: 11 |